Comprehensive Insights Into Renal Perivascular Epithelioid Cell Neoplasms: From Molecular Mechanisms to Clinical Practice
- PMID: 38751707
- PMCID: PMC11092404
- DOI: 10.14740/wjon1794
Comprehensive Insights Into Renal Perivascular Epithelioid Cell Neoplasms: From Molecular Mechanisms to Clinical Practice
Abstract
Perivascular epithelioid cell neoplasms (PEComas) are a rare category of mesenchymal tissue tumors, manifesting across various tissues and organs such as the kidneys, liver, lungs, pancreas, uterus, ovaries, and gastrointestinal tract. They predominantly affect females more than males. PEComas characteristically express both melanocytic and smooth muscle markers, making immunohistochemistry vital for their diagnosis. Renal angiomyolipoma (AML) represents a common variant of PEComas, typically marked by favorable prognoses. Nonetheless, only a small fraction of subtypes, especially epithelioid AML, possess the capacity to be malignant. Renal PEComas usually appear as asymptomatic masses accompanied by vague imaging characteristics. The main methods for diagnosis are histopathological analysis and the application of immunohistochemical stains. Presently, a uniform treatment plan for renal PEComas is absent. Strategies for management include active surveillance, selective arterial embolization, surgical procedures, and drug-based treatments. The focus of this review is on renal PEComas, shedding light on their pathogenesis, pathological characteristics, clinical presentations, diagnosis, and treatment modalities, and incorporating a clinical case study.
Keywords: Angiomyolipoma; Etiology; Immunohistochemistry; Perivascular epithelioid cell neoplasms; Therapeutics.
Copyright 2024, Dong et al.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.Am J Surg Pathol. 2005 Dec;29(12):1558-75. doi: 10.1097/01.pas.0000173232.22117.37. Am J Surg Pathol. 2005. PMID: 16327428 Review.
-
[Perivascular epithelioid cell tumor of urinary system: a clinicopathologic analysis of 21 cases].Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):443-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.003. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22932453 Chinese.
-
PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours.Histopathology. 2018 Feb;72(3):441-448. doi: 10.1111/his.13369. Epub 2017 Nov 21. Histopathology. 2018. PMID: 28837273
-
Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm.J Clin Transl Hepatol. 2022 Feb 28;10(1):72-79. doi: 10.14218/JCTH.2020.00170. Epub 2021 Jun 21. J Clin Transl Hepatol. 2022. PMID: 35233375 Free PMC article.
-
Uterine perivascular epithelioid cell neoplasms (PEComas): report of two cases and literature review.Eur J Gynaecol Oncol. 2014;35(3):309-12. Eur J Gynaecol Oncol. 2014. PMID: 24984548 Review.
Cited by
-
Characteristics and Treatment of Primary Hepatic Perivascular Epithelioid Cell Tumor (PEComa) in Adults: A Systematic Review.Cancers (Basel). 2025 Jul 8;17(14):2276. doi: 10.3390/cancers17142276. Cancers (Basel). 2025. PMID: 40723161 Free PMC article. Review.
References
-
- The WHO Classification of Tumours Editorial Board. WHO Classification of Tumours Soft Tissue and Bone Tumours, 5th Ed. Lyon: IARC Press; 2020.
-
- Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29(12):1558–1575. doi: 10.1097/01.pas.0000173232.22117.37. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources